Silo Pharma, Inc.
SILO
$1.07
$0.04484.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.00K | 18.00K | 18.00K | 18.00K | 18.00K |
| Cost of Revenue | 1.50K | 1.50K | 1.50K | 1.50K | 1.40K |
| Gross Profit | 16.60K | 16.60K | 16.60K | 16.60K | 16.60K |
| SG&A Expenses | 754.20K | 509.10K | 626.50K | 577.80K | 843.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.83M | 1.03M | 1.02M | 897.50K | 1.18M |
| Operating Income | -1.81M | -1.01M | -1.00M | -879.50K | -1.16M |
| Income Before Tax | -1.73M | -928.80K | -931.80K | -801.70K | -1.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.73M | -928.80K | -931.80K | -801.70K | -1.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.73M | -928.80K | -931.80K | -801.70K | -1.12M |
| EBIT | -1.81M | -1.01M | -1.00M | -879.50K | -1.16M |
| EBITDA | -1.81M | -1.01M | -- | -- | -- |
| EPS Basic | -0.39 | -0.22 | -0.31 | -0.28 | -0.38 |
| Normalized Basic EPS | -0.24 | -0.13 | -0.19 | -0.17 | -0.22 |
| EPS Diluted | -0.39 | -0.22 | -0.31 | -0.28 | -0.38 |
| Normalized Diluted EPS | -0.24 | -0.13 | -0.19 | -0.17 | -0.22 |
| Average Basic Shares Outstanding | 4.49M | 4.30M | 3.05M | 2.87M | 3.08M |
| Average Diluted Shares Outstanding | 4.49M | 4.30M | 3.05M | 2.87M | 3.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |